MIDDLE EAST HEALTHCARE COMPANY |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 93 SAR | -2.11% |
|
-2.52% | +5.32% |
| Sales 2024 * | 2.98B 796M | Sales 2025 * | 3.43B 914M | Capitalization | 8.56B 2.28B |
|---|---|---|---|---|---|
| Net income 2024 * | 269M 71.76M | Net income 2025 * | 363M 96.84M | EV / Sales 2024 * | 3.62 x |
| Net Debt 2024 * | 2.25B 599M | Net Debt 2025 * | 2.02B 540M | EV / Sales 2025 * | 3.09 x |
| P/E ratio 2024 * |
33.1
x | P/E ratio 2025 * |
24.5
x | Employees | 4,220 |
| Yield 2024 * |
0.72% | Yield 2025 * |
0.87% | Free-Float | 45.31% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.11% | ||
| 1 week | -2.52% | ||
| Current month | -6.06% | ||
| 1 month | -15.91% | ||
| 3 months | -3.23% | ||
| 6 months | +42.86% | ||
| Current year | +5.32% |
1 week
92.20
98.30
1 month
86.40117.40
Current year
86.40134.40
1 year
37.55134.40
3 years
25.00134.40
5 years
23.88134.40
10 years
23.88134.40
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 18-12-04 | |
| Director of Finance/CFO | - | 19-07-14 | |
| President | 45 | 14-09-16 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 19-11-09 | |
Sobhi Batterjee
CHM | Chairman | - | 14-09-16 |
| Director/Board Member | - | 14-09-16 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 34 M€ | +2.35% | - | |
| 0.00% | 117 M€ | +0.68% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 93 | -2.11% | 204,195 |
| 24-04-23 | 95 | -0.84% | 219,244 |
| 24-04-22 | 95.8 | +1.70% | 417,271 |
| 24-04-21 | 94.2 | +0.64% | 183,094 |
| 24-04-18 | 93.6 | -1.89% | 282,752 |
End-of-day quote Saudi Arabian S.E., April 23, 2024
More quotes
Middle East Healthcare Co SJSC is a Saudi Arabia-based Healthcare company. The Company manages, operates and maintains hospitals, medical centers, educational centers, rehabilitation centers, physiotherapy, laboratories and radiology centers, pharmacies purchasing of lands to construct buildings and investment for the Company in medical projects.
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
93
SAR
Average target price
86.77
SAR
Spread / Average Target
-6.70%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.32% | 2.28B | |
| -24.40% | 15.4B | |
| +1.80% | 12.12B | |
| +2.82% | 11.43B | |
| +10.99% | 10.84B | |
| +24.10% | 8.29B | |
| -0.40% | 7.78B | |
| +22.90% | 7.33B | |
| +5.73% | 6.75B | |
| +50.39% | 4.65B |
- Stock Market
- Equities
- 4009 Stock
